These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 10825241)

  • 1. Intracellular osteopontin is an integral component of the CD44-ERM complex involved in cell migration.
    Zohar R; Suzuki N; Suzuki K; Arora P; Glogauer M; McCulloch CA; Sodek J
    J Cell Physiol; 2000 Jul; 184(1):118-30. PubMed ID: 10825241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteopontin modulates CD44-dependent chemotaxis of peritoneal macrophages through G-protein-coupled receptors: evidence of a role for an intracellular form of osteopontin.
    Zhu B; Suzuki K; Goldberg HA; Rittling SR; Denhardt DT; McCulloch CA; Sodek J
    J Cell Physiol; 2004 Jan; 198(1):155-67. PubMed ID: 14584055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colocalization of intracellular osteopontin with CD44 is associated with migration, cell fusion, and resorption in osteoclasts.
    Suzuki K; Zhu B; Rittling SR; Denhardt DT; Goldberg HA; McCulloch CA; Sodek J
    J Bone Miner Res; 2002 Aug; 17(8):1486-97. PubMed ID: 12162503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single cell analysis of intracellular osteopontin in osteogenic cultures of fetal rat calvarial cells.
    Zohar R; Lee W; Arora P; Cheifetz S; McCulloch C; Sodek J
    J Cell Physiol; 1997 Jan; 170(1):88-100. PubMed ID: 9012788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteopontin increases CD44 expression and cell adhesion in RAW 264.7 murine leukemia cells.
    Marroquin CE; Downey L; Guo H; Kuo PC
    Immunol Lett; 2004 Aug; 95(1):109-12. PubMed ID: 15325806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of hyaluronan binding by F-actin and colocalization of CD44 and phosphorylated ezrin/radixin/moesin (ERM) proteins in myeloid cells.
    Brown KL; Birkenhead D; Lai JC; Li L; Li R; Johnson P
    Exp Cell Res; 2005 Feb; 303(2):400-14. PubMed ID: 15652352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-V-dependent outside-in signaling is required for the regulation of CD44 surface expression, MMP-2 secretion, and cell migration by osteopontin in human melanoma cells.
    Samanna V; Wei H; Ego-Osuala D; Chellaiah MA
    Exp Cell Res; 2006 Jul; 312(12):2214-30. PubMed ID: 16631740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of ezrin/radixin/moesin (ERM) and ERM-associated adhesion molecules in the blastocyst and uterus suggests their functions during implantation.
    Matsumoto H; Daikoku T; Wang H; Sato E; Dey SK
    Biol Reprod; 2004 Mar; 70(3):729-36. PubMed ID: 14613898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autocrine activation of an osteopontin-CD44-Rac pathway enhances invasion and transformation by H-RasV12.
    Teramoto H; Castellone MD; Malek RL; Letwin N; Frank B; Gutkind JS; Lee NH
    Oncogene; 2005 Jan; 24(3):489-501. PubMed ID: 15516973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD44 variants but not CD44s cooperate with beta1-containing integrins to permit cells to bind to osteopontin independently of arginine-glycine-aspartic acid, thereby stimulating cell motility and chemotaxis.
    Katagiri YU; Sleeman J; Fujii H; Herrlich P; Hotta H; Tanaka K; Chikuma S; Yagita H; Okumura K; Murakami M; Saiki I; Chambers AF; Uede T
    Cancer Res; 1999 Jan; 59(1):219-26. PubMed ID: 9892210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential regulation of osteopontin receptors, CD44 and the alpha(v) and beta(3) integrin subunits, in the rat hippocampus following transient forebrain ischemia.
    Kang WS; Choi JS; Shin YJ; Kim HY; Cha JH; Lee JY; Chun MH; Lee MY
    Brain Res; 2008 Sep; 1228():208-16. PubMed ID: 18638458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteopontin is an autocrine mediator of hepatocyte growth factor-induced invasive growth.
    Medico E; Gentile A; Lo Celso C; Williams TA; Gambarotta G; Trusolino L; Comoglio PM
    Cancer Res; 2001 Aug; 61(15):5861-8. PubMed ID: 11479227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The involvement of osteopontin and its receptors in multiple myeloma cell survival, migration and invasion in the murine 5T33MM model.
    Caers J; Günthert U; De Raeve H; Van Valckenborgh E; Menu E; Van Riet I; Van Camp B; Vanderkerken K
    Br J Haematol; 2006 Feb; 132(4):469-77. PubMed ID: 16412019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming JB6 cells exhibit enhanced integrin-mediated adhesion to osteopontin.
    Chang PL; Chambers AF
    J Cell Biochem; 2000 Apr; 78(1):8-23. PubMed ID: 10797562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secretion of Osteopontin by macrophages and its accumulation at tissue surfaces during wound healing in mineralized tissues: a potential requirement for macrophage adhesion and phagocytosis.
    McKee MD; Nanci A
    Anat Rec; 1996 Jun; 245(2):394-409. PubMed ID: 8769675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific reduction in osteopontin synthesis by antisense RNA inhibits the tumorigenicity of transformed Rat1 fibroblasts.
    Gardner HA; Berse B; Senger DR
    Oncogene; 1994 Aug; 9(8):2321-6. PubMed ID: 8036014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrin-linked kinase regulates osteopontin-dependent MMP-2 and uPA expression to convey metastatic function in murine mammary epithelial cancer cells.
    Mi Z; Guo H; Wai PY; Gao C; Kuo PC
    Carcinogenesis; 2006 Jun; 27(6):1134-45. PubMed ID: 16474180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteopontin promotes integrin activation through outside-in and inside-out mechanisms: OPN-CD44V interaction enhances survival in gastrointestinal cancer cells.
    Lee JL; Wang MJ; Sudhir PR; Chen GD; Chi CW; Chen JY
    Cancer Res; 2007 Mar; 67(5):2089-97. PubMed ID: 17332338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta(3) integrin expression increases breast carcinoma cell responsiveness to the malignancy-enhancing effects of osteopontin.
    Furger KA; Allan AL; Wilson SM; Hota C; Vantyghem SA; Postenka CO; Al-Katib W; Chambers AF; Tuck AB
    Mol Cancer Res; 2003 Sep; 1(11):810-9. PubMed ID: 14517343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of osteopontin messenger RNA and protein in rheumatoid arthritis: effects of osteopontin on the release of collagenase 1 from articular chondrocytes and synovial fibroblasts.
    Petrow PK; Hummel KM; Schedel J; Franz JK; Klein CL; Müller-Ladner U; Kriegsmann J; Chang PL; Prince CW; Gay RE; Gay S
    Arthritis Rheum; 2000 Jul; 43(7):1597-605. PubMed ID: 10902765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.